ViaCyte raises $10.6 million

ViaCyte said the financing included its largest existing investors: Johnson & Johnson Development Corp., Sanderling Ventures and Asset Management Co.

http://www.utsandiego.com/news/2013/jul/11/viacyte-funding-diabetes/